Clinical Trial Results TV
November 10, 2005: Risk Stratification in the Care of ACS: The Role of the ED in Matching Treatment to Risk in Cardiac Care
This video is sponsored by the Duke Clinical Medical Series.

Topics include:
* Risk Stratification in the Care of ACS: The Role of the ED in Matching Treatment to
Risk in Cardiac Care
* Serum Markers of AMI: Myoglobin
* TIMI Risk Score (NSTE-ACS)
* Level 2 (High-risk) ACS Clinical Features:
* ACS Diagnostic Flow Summary


The moderator, Kristin Newby, MD, has indicated that she receives research/grant support
from Bristol-Myers Squibb, Sanofi, Millennium Pharmaceuticals, Inc., Schering-Plough
Research Institute, Novartis and Roche Diagnostics Corporation. Dr. Newby is also a member
of an advisory board for Eli Lilly and a consultant for Proctor and Gamble; she has spoken
at scientific symposia for Aventis, Bristol-Myers Squibb, Sanofi and Millennium
Pharmaceuticals, Inc.

The guest faculty, James Hoekstra, MD, has indicated that he is an honorarium recipient of
Schering Plough, The sanofi-aventis Group, Bristol-Myers Squibb, and the Medicine's
Company.



Risk Stratification in the Care of ACS: The Role of the ED in Matching Treatment to Risk in Cardiac Care

Please select your viewing options:

Windows Media: 56k 100k
RealPlayer: 56k 100k
Number Viewing:
Need a media player? Please choose one of the free downloads below:
Get Windows Media PlayerDownload RealPlayer

Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
08-21-2018 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted